Hard to Treat Diseases Inc.
Hard to Treat Diseases Inc. HTDS Peers
See (HTDS) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HTDS | $0.00 | +0.00% | 109.6K | N/A | N/A | N/A |
| NONOF | $68.00 | -4.56% | 301.9B | 19.05 | $3.57 | +2.44% |
| CSLLY | $79.49 | -1.60% | 154B | 29.22 | $2.72 | +1.67% |
| CMXHF | $154.72 | +0.00% | 74.9B | 28.39 | $5.45 | +1.75% |
| ARGNF | $562.00 | N/A | 34.3B | 34.25 | $16.41 | N/A |
| UCBJF | $175.75 | +0.69% | 33.4B | 28.17 | $6.24 | +0.80% |
| UCBJY | $87.75 | -2.32% | 33.4B | 28.13 | $3.12 | +0.90% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| GNMSF | $209.75 | -0.17% | 12.9B | 12.31 | $17.04 | N/A |
| IVBXF | $7.55 | N/A | 12.5B | -755.00 | -$0.01 | N/A |
Stock Comparison
HTDS vs NONOF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, NONOF has a market cap of 301.9B. Regarding current trading prices, HTDS is priced at $0.00, while NONOF trades at $68.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 19.05. In terms of profitability, HTDS's ROE is N/A, compared to NONOF's ROE of +0.81%. Regarding short-term risk, HTDS is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CSLLY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CSLLY has a market cap of 154B. Regarding current trading prices, HTDS is priced at $0.00, while CSLLY trades at $79.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 29.22. In terms of profitability, HTDS's ROE is N/A, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, HTDS is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CMXHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CMXHF has a market cap of 74.9B. Regarding current trading prices, HTDS is priced at $0.00, while CMXHF trades at $154.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 28.39. In terms of profitability, HTDS's ROE is N/A, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, HTDS is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ARGNF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ARGNF has a market cap of 34.3B. Regarding current trading prices, HTDS is priced at $0.00, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, HTDS's ROE is N/A, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, HTDS is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs UCBJF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, UCBJF has a market cap of 33.4B. Regarding current trading prices, HTDS is priced at $0.00, while UCBJF trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 28.17. In terms of profitability, HTDS's ROE is N/A, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, HTDS is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs UCBJY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, UCBJY has a market cap of 33.4B. Regarding current trading prices, HTDS is priced at $0.00, while UCBJY trades at $87.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 28.13. In terms of profitability, HTDS's ROE is N/A, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, HTDS is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ODTC Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, HTDS is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is -0.08. In terms of profitability, HTDS's ROE is N/A, compared to ODTC's ROE of +0.07%. Regarding short-term risk, HTDS is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs GNMSF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, GNMSF has a market cap of 12.9B. Regarding current trading prices, HTDS is priced at $0.00, while GNMSF trades at $209.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 12.31. In terms of profitability, HTDS's ROE is N/A, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, HTDS is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs IVBXF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, IVBXF has a market cap of 12.5B. Regarding current trading prices, HTDS is priced at $0.00, while IVBXF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is -755.00. In terms of profitability, HTDS's ROE is N/A, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, HTDS is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs WXIBF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, WXIBF has a market cap of 12.2B. Regarding current trading prices, HTDS is priced at $0.00, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, HTDS's ROE is N/A, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, HTDS is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs WXXWY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, WXXWY has a market cap of 11.9B. Regarding current trading prices, HTDS is priced at $0.00, while WXXWY trades at $5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 26.64. In terms of profitability, HTDS's ROE is N/A, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, HTDS is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SBMFF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SBMFF has a market cap of 9.7B. Regarding current trading prices, HTDS is priced at $0.00, while SBMFF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 54.20. In terms of profitability, HTDS's ROE is N/A, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, HTDS is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SBHMY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SBHMY has a market cap of 8.5B. Regarding current trading prices, HTDS is priced at $0.00, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, HTDS's ROE is N/A, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, HTDS is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs TRSBF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, HTDS is priced at $0.00, while TRSBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 23.64. In terms of profitability, HTDS's ROE is N/A, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, HTDS is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs TLPPF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, TLPPF has a market cap of 5.6B. Regarding current trading prices, HTDS is priced at $0.00, while TLPPF trades at $16.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is 183.80. In terms of profitability, HTDS's ROE is N/A, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, HTDS is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ABCZF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, HTDS is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, HTDS's ROE is N/A, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, HTDS is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ZLDPF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ZLDPF has a market cap of 4.9B. Regarding current trading prices, HTDS is priced at $0.00, while ZLDPF trades at $69.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is -26.36. In terms of profitability, HTDS's ROE is N/A, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, HTDS is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs INCPF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, HTDS is priced at $0.00, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is -108.67. In terms of profitability, HTDS's ROE is N/A, compared to INCPF's ROE of -0.05%. Regarding short-term risk, HTDS is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs AKBLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, AKBLF has a market cap of 4.8B. Regarding current trading prices, HTDS is priced at $0.00, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 33.36. In terms of profitability, HTDS's ROE is N/A, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, HTDS is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs LABFF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, HTDS is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, HTDS's ROE is N/A, compared to LABFF's ROE of +0.39%. Regarding short-term risk, HTDS is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs REGMF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, HTDS is priced at $0.00, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is -13.32. In terms of profitability, HTDS's ROE is N/A, compared to REGMF's ROE of -0.48%. Regarding short-term risk, HTDS is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SHJBF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SHJBF has a market cap of 3.4B. Regarding current trading prices, HTDS is priced at $0.00, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, HTDS's ROE is N/A, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, HTDS is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CAMRF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, HTDS is priced at $0.00, while CAMRF trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 58.33. In terms of profitability, HTDS's ROE is N/A, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, HTDS is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs GNNSF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, GNNSF has a market cap of 2.9B. Regarding current trading prices, HTDS is priced at $0.00, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, HTDS's ROE is N/A, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, HTDS is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs TKBIF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, HTDS is priced at $0.00, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, HTDS's ROE is N/A, compared to TKBIF's ROE of N/A. Regarding short-term risk, HTDS is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs MPSYF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, HTDS is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, HTDS's ROE is N/A, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, HTDS is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ASPHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, HTDS is priced at $0.00, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, HTDS's ROE is N/A, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, HTDS is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BVNKF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, HTDS is priced at $0.00, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 10.47. In terms of profitability, HTDS's ROE is N/A, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, HTDS is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BVNRY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BVNRY has a market cap of 2B. Regarding current trading prices, HTDS is priced at $0.00, while BVNRY trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 10.23. In terms of profitability, HTDS's ROE is N/A, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, HTDS is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BTTAY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, HTDS is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, HTDS's ROE is N/A, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, HTDS is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs GENSF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, GENSF has a market cap of 1.8B. Regarding current trading prices, HTDS is priced at $0.00, while GENSF trades at $27.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is -348.31. In terms of profitability, HTDS's ROE is N/A, compared to GENSF's ROE of +0.01%. Regarding short-term risk, HTDS is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs MEOBF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, MEOBF has a market cap of 1.8B. Regarding current trading prices, HTDS is priced at $0.00, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, HTDS's ROE is N/A, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, HTDS is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs GLPGF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, GLPGF has a market cap of 1.8B. Regarding current trading prices, HTDS is priced at $0.00, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -8.87. In terms of profitability, HTDS's ROE is N/A, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, HTDS is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PPTDF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PPTDF has a market cap of 1.7B. Regarding current trading prices, HTDS is priced at $0.00, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is 16.91. In terms of profitability, HTDS's ROE is N/A, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, HTDS is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PHMMF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, HTDS is priced at $0.00, while PHMMF trades at $96.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 75.16. In terms of profitability, HTDS's ROE is N/A, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, HTDS is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ONTTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, HTDS is priced at $0.00, while ONTTF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -8.24. In terms of profitability, HTDS's ROE is N/A, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, HTDS is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BRCTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, HTDS is priced at $0.00, while BRCTF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 17.68. In terms of profitability, HTDS's ROE is N/A, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, HTDS is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BIESF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, HTDS is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, HTDS's ROE is N/A, compared to BIESF's ROE of +0.05%. Regarding short-term risk, HTDS is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BRAXF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, HTDS is priced at $0.00, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, HTDS's ROE is N/A, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, HTDS is more volatile compared to BRAXF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CSBTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CSBTF has a market cap of 1.2B. Regarding current trading prices, HTDS is priced at $0.00, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, HTDS's ROE is N/A, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, HTDS is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs NURPF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, HTDS is priced at $0.00, while NURPF trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 11.67. In terms of profitability, HTDS's ROE is N/A, compared to NURPF's ROE of +0.49%. Regarding short-term risk, HTDS is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SNBIF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SNBIF has a market cap of 954.4M. Regarding current trading prices, HTDS is priced at $0.00, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, HTDS's ROE is N/A, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, HTDS is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ASCLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ASCLF has a market cap of 865.8M. Regarding current trading prices, HTDS is priced at $0.00, while ASCLF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -22.33. In terms of profitability, HTDS's ROE is N/A, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, HTDS is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CSPHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CSPHF has a market cap of 703M. Regarding current trading prices, HTDS is priced at $0.00, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, HTDS's ROE is N/A, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, HTDS is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PHGUF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PHGUF has a market cap of 680.3M. Regarding current trading prices, HTDS is priced at $0.00, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, HTDS's ROE is N/A, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, HTDS is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BPMUF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BPMUF has a market cap of 582.7M. Regarding current trading prices, HTDS is priced at $0.00, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 6.73. In terms of profitability, HTDS's ROE is N/A, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, HTDS is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs INRLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, HTDS is priced at $0.00, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -5.08. In terms of profitability, HTDS's ROE is N/A, compared to INRLF's ROE of -0.43%. Regarding short-term risk, HTDS is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BXPHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BXPHF has a market cap of 519.6M. Regarding current trading prices, HTDS is priced at $0.00, while BXPHF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BXPHF's P/E ratio is -26.50. In terms of profitability, HTDS's ROE is N/A, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, HTDS is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs IVEVF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, IVEVF has a market cap of 505.9M. Regarding current trading prices, HTDS is priced at $0.00, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, HTDS's ROE is N/A, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, HTDS is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CLTEF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, HTDS is priced at $0.00, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, HTDS's ROE is N/A, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, HTDS is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs VBIZF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, VBIZF has a market cap of 504.2M. Regarding current trading prices, HTDS is priced at $0.00, while VBIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 24.20. In terms of profitability, HTDS's ROE is N/A, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, HTDS is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SOLTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SOLTF has a market cap of 497.1M. Regarding current trading prices, HTDS is priced at $0.00, while SOLTF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -30.56. In terms of profitability, HTDS's ROE is N/A, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, HTDS is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CKDXF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CKDXF has a market cap of 475.3M. Regarding current trading prices, HTDS is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, HTDS's ROE is N/A, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, HTDS is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs AAVXF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, HTDS is priced at $0.00, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -2.27. In terms of profitability, HTDS's ROE is N/A, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, HTDS is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs TBGNF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, HTDS is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, HTDS's ROE is N/A, compared to TBGNF's ROE of N/A. Regarding short-term risk, HTDS is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CYDY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CYDY has a market cap of 415.3M. Regarding current trading prices, HTDS is priced at $0.00, while CYDY trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -16.85. In terms of profitability, HTDS's ROE is N/A, compared to CYDY's ROE of +0.07%. Regarding short-term risk, HTDS is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs HBMHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, HBMHF has a market cap of 407.9M. Regarding current trading prices, HTDS is priced at $0.00, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, HTDS's ROE is N/A, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, HTDS is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PTCHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PTCHF has a market cap of 403.5M. Regarding current trading prices, HTDS is priced at $0.00, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, HTDS's ROE is N/A, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, HTDS is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs IDRSF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, IDRSF has a market cap of 379.1M. Regarding current trading prices, HTDS is priced at $0.00, while IDRSF trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -1.13. In terms of profitability, HTDS's ROE is N/A, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, HTDS is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs NWBO Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, NWBO has a market cap of 369.9M. Regarding current trading prices, HTDS is priced at $0.00, while NWBO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -4.28. In terms of profitability, HTDS's ROE is N/A, compared to NWBO's ROE of +1.13%. Regarding short-term risk, HTDS is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CLVLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CLVLF has a market cap of 348.4M. Regarding current trading prices, HTDS is priced at $0.00, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, HTDS's ROE is N/A, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, HTDS is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CLVLY Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CLVLY has a market cap of 340.3M. Regarding current trading prices, HTDS is priced at $0.00, while CLVLY trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 13.58. In terms of profitability, HTDS's ROE is N/A, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, HTDS is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BOVNF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BOVNF has a market cap of 309.3M. Regarding current trading prices, HTDS is priced at $0.00, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, HTDS's ROE is N/A, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, HTDS is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PRRUF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PRRUF has a market cap of 306.7M. Regarding current trading prices, HTDS is priced at $0.00, while PRRUF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -10.50. In terms of profitability, HTDS's ROE is N/A, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, HTDS is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PBBIF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, HTDS is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, HTDS's ROE is N/A, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, HTDS is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs NGENF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, NGENF has a market cap of 278.3M. Regarding current trading prices, HTDS is priced at $0.00, while NGENF trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -14.33. In terms of profitability, HTDS's ROE is N/A, compared to NGENF's ROE of -2.23%. Regarding short-term risk, HTDS is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ORYZF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, HTDS is priced at $0.00, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, HTDS's ROE is N/A, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, HTDS is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs NWPHF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, HTDS is priced at $0.00, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, HTDS's ROE is N/A, compared to NWPHF's ROE of N/A. Regarding short-term risk, HTDS is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs MDCLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, HTDS is priced at $0.00, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, HTDS's ROE is N/A, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, HTDS is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs HLOSF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, HLOSF has a market cap of 228.3M. Regarding current trading prices, HTDS is priced at $0.00, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -7.03. In terms of profitability, HTDS's ROE is N/A, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, HTDS is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs RAONF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, RAONF has a market cap of 212M. Regarding current trading prices, HTDS is priced at $0.00, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -20.33. In terms of profitability, HTDS's ROE is N/A, compared to RAONF's ROE of -0.71%. Regarding short-term risk, HTDS is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs FPHAF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, HTDS is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, HTDS's ROE is N/A, compared to FPHAF's ROE of N/A. Regarding short-term risk, HTDS is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs VSBC Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, HTDS is priced at $0.00, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas VSBC's P/E ratio is N/A. In terms of profitability, HTDS's ROE is N/A, compared to VSBC's ROE of +0.00%. Regarding short-term risk, HTDS is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs FGHQF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, HTDS is priced at $0.00, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, HTDS's ROE is N/A, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, HTDS is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SPHDF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SPHDF has a market cap of 204.7M. Regarding current trading prices, HTDS is priced at $0.00, while SPHDF trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -3.93. In terms of profitability, HTDS's ROE is N/A, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, HTDS is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs HNSBF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, HNSBF has a market cap of 203.4M. Regarding current trading prices, HTDS is priced at $0.00, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, HTDS's ROE is N/A, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, HTDS is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BSEM Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BSEM has a market cap of 187.9M. Regarding current trading prices, HTDS is priced at $0.00, while BSEM trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BSEM's P/E ratio is -20.18. In terms of profitability, HTDS's ROE is N/A, compared to BSEM's ROE of +1.50%. Regarding short-term risk, HTDS is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs GNFTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, GNFTF has a market cap of 176.3M. Regarding current trading prices, HTDS is priced at $0.00, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, HTDS's ROE is N/A, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, HTDS is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SCNLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SCNLF has a market cap of 176M. Regarding current trading prices, HTDS is priced at $0.00, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, HTDS's ROE is N/A, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, HTDS is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs OPORF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, HTDS is priced at $0.00, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas OPORF's P/E ratio is 12.00. In terms of profitability, HTDS's ROE is N/A, compared to OPORF's ROE of +0.42%. Regarding short-term risk, HTDS is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs RECEF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, RECEF has a market cap of 157.2M. Regarding current trading prices, HTDS is priced at $0.00, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -10.00. In terms of profitability, HTDS's ROE is N/A, compared to RECEF's ROE of +2.26%. Regarding short-term risk, HTDS is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs MLLCF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, HTDS is priced at $0.00, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -2.05. In terms of profitability, HTDS's ROE is N/A, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, HTDS is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs AVCTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, AVCTF has a market cap of 153.8M. Regarding current trading prices, HTDS is priced at $0.00, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, HTDS's ROE is N/A, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, HTDS is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs SLNCF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, SLNCF has a market cap of 137.4M. Regarding current trading prices, HTDS is priced at $0.00, while SLNCF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -1.90. In terms of profitability, HTDS's ROE is N/A, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, HTDS is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs BRIBF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, BRIBF has a market cap of 134.1M. Regarding current trading prices, HTDS is priced at $0.00, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, HTDS's ROE is N/A, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, HTDS is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs IPHYF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, IPHYF has a market cap of 133.6M. Regarding current trading prices, HTDS is priced at $0.00, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, HTDS's ROE is N/A, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, HTDS is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs AAPGV Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, HTDS is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, HTDS's ROE is N/A, compared to AAPGV's ROE of N/A. Regarding short-term risk, HTDS is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs IUGNF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, IUGNF has a market cap of 126.9M. Regarding current trading prices, HTDS is priced at $0.00, while IUGNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas IUGNF's P/E ratio is -1.70. In terms of profitability, HTDS's ROE is N/A, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, HTDS is more volatile compared to IUGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PRNAF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PRNAF has a market cap of 126.9M. Regarding current trading prices, HTDS is priced at $0.00, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, HTDS's ROE is N/A, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, HTDS is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs AMGXF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, AMGXF has a market cap of 121.8M. Regarding current trading prices, HTDS is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, HTDS's ROE is N/A, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, HTDS is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PSTTF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, HTDS is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, HTDS's ROE is N/A, compared to PSTTF's ROE of N/A. Regarding short-term risk, HTDS is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs EPRXF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, HTDS is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, HTDS's ROE is N/A, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, HTDS is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ADOIF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, HTDS is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, HTDS's ROE is N/A, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, HTDS is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs PBIGF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, PBIGF has a market cap of 100M. Regarding current trading prices, HTDS is priced at $0.00, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, HTDS's ROE is N/A, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, HTDS is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs TRGNF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, HTDS is priced at $0.00, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, HTDS's ROE is N/A, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, HTDS is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs CMVLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, CMVLF has a market cap of 90.1M. Regarding current trading prices, HTDS is priced at $0.00, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -1.87. In terms of profitability, HTDS's ROE is N/A, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, HTDS is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs ACHFF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, ACHFF has a market cap of 87M. Regarding current trading prices, HTDS is priced at $0.00, while ACHFF trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas ACHFF's P/E ratio is -33.00. In terms of profitability, HTDS's ROE is N/A, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, HTDS is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs MCURF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, HTDS is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, HTDS's ROE is N/A, compared to MCURF's ROE of -1.02%. Regarding short-term risk, HTDS is more volatile compared to MCURF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.
HTDS vs MSCLF Comparison
HTDS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HTDS stands at 109.6K. In comparison, MSCLF has a market cap of 84.6M. Regarding current trading prices, HTDS is priced at $0.00, while MSCLF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HTDS currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 3.00. In terms of profitability, HTDS's ROE is N/A, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, HTDS is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HTDS.